Document Preview Unavailable
Silencing of the CrkL gene reverses the doxorubicin resistance of K562/ADR cells through regulating PI3K/Akt/MRP1 signaling
Jiang, Yu; Wen‐XU Chen; Wen‐Jing Xie; Rong‐Wei Chen; Dan‐Qi Lin; et al. Journal of Clinical Laboratory Analysis Vol. 35, Iss. 8, (Aug 2021).You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library




